Publications

Beyond bulk: Resolving RNASeq/mass spectrometry/IHC discrepancies with multiplexed spatial profiling and 3D cluster

Development of a virtual Cyclin E1 biomarker using Deep Learning from H&E slides for predicting Cyclin E1 overexpression in gynecological…

Clinical Outcome of Afabicin in Bone and Joint Infections: Efficacy and Safety Findings from a Phase 2 Trial of a…

Enhancing therapeutic efficacy and overcoming resistance with a novel dual-payload antibody-drug conjugate technology

Afabicin Desphosphono in Vitro Activity Against Staphylococcus Spp. Data From A Five-Year Susceptibility Surveillance Study (2018-2023)

A phase 1/2, first-in-human, multicenter, open-label trial evaluating the safety, tolerability, and antileukemic activity of Debio1562M in patients with recurrent…

Bioanalytical and biosample management strategies to support a first-in-human trial of an investigational cyclic peptidomimetic radioligand agent

A Large Molecular Model (LMM)-Based Predictor of Clinical Response to the WEE1 Inhibitor Debio 0123 + Carboplatin Therapy

The bactericidal FabI inhibitor Debio 1453 clears antibiotic-resistant Neisseria gonorrhoeae infection in vivo